800401-71-2 Usage
Uses
Used in Pharmaceutical Industry:
5-bromo-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is used as a building block for the development of new drugs and pharmacologically active compounds due to its unique molecular structure and potential biological activities.
Used in Chemical Synthesis:
5-bromo-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is used as a reactant in coupling reactions for the synthesis of complex organic compounds, leveraging its bromine atom and carboxylic acid group.
Used in Drug Development:
5-bromo-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is used as a research compound to explore its potential applications in drug development, given its diverse biological activities and unique structure.
Used in Organic Synthesis Research:
5-bromo-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is used as a subject of study in organic synthesis research to understand its reactivity, properties, and potential applications in creating new chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 800401-71-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,0,0,4,0 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 800401-71:
(8*8)+(7*0)+(6*0)+(5*4)+(4*0)+(3*1)+(2*7)+(1*1)=102
102 % 10 = 2
So 800401-71-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2O2/c9-7-2-4-1-5(8(12)13)11-6(4)3-10-7/h1-3,11H,(H,12,13)
800401-71-2Relevant articles and documents
AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS
-
, (2021/04/02)
Provided herein are compounds of Formula (I) and Formula (II): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of tuberculosis.
PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE
-
Page 41, (2008/06/13)
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.